C
CanariaBio Inc
KOSDAQ:016790
CanariaBio Inc
KOSDAQ:016790
Price:
994
KRW
Market Closed
Market Cap:
₩187.3B
Balance Sheet
Balance Sheet Decomposition
CanariaBio Inc
CanariaBio Inc
Balance Sheet Decomposition is not available for
CanariaBio Inc
CanariaBio Inc
Balance Sheet
CanariaBio Inc
CanariaBio Inc
Currency: KRW
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
13 870
|
7 193
|
5 347
|
2 950
|
1 836
|
6 074
|
5 394
|
6 747
|
|
| Cash |
13 870
|
7 193
|
5 347
|
2 950
|
1 836
|
6 074
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
5 394
|
6 747
|
|
| Short-Term Investments |
4 059
|
895
|
9 405
|
4 800
|
200
|
7 995
|
0
|
160
|
|
| Total Receivables |
40 171
|
37 990
|
37 684
|
50 600
|
55 001
|
49 021
|
43 349
|
57 298
|
|
| Accounts Receivables |
32 930
|
34 268
|
33 336
|
50 432
|
54 374
|
47 383
|
31 390
|
37 907
|
|
| Other Receivables |
7 241
|
3 722
|
4 348
|
168
|
627
|
1 638
|
11 959
|
19 391
|
|
| Inventory |
16 908
|
11 053
|
9 152
|
12 418
|
16 398
|
12 047
|
16 210
|
19 088
|
|
| Other Current Assets |
10 678
|
4 545
|
3 073
|
974
|
1 470
|
534
|
1 234
|
7 732
|
|
| Total Current Assets |
85 686
|
61 677
|
64 661
|
71 743
|
74 904
|
75 671
|
66 186
|
91 026
|
|
| PP&E Net |
18 320
|
18 432
|
18 289
|
18 753
|
19 062
|
18 835
|
25 946
|
30 039
|
|
| PP&E Gross |
18 320
|
18 432
|
18 289
|
18 753
|
19 062
|
18 835
|
25 946
|
30 039
|
|
| Accumulated Depreciation |
9 066
|
9 517
|
9 880
|
10 379
|
10 758
|
11 158
|
11 204
|
11 551
|
|
| Intangible Assets |
413
|
413
|
626
|
626
|
626
|
913
|
844
|
145 631
|
|
| Note Receivable |
2 465
|
2 230
|
1 060
|
2 695
|
2 651
|
2 678
|
630
|
4 230
|
|
| Long-Term Investments |
409
|
10
|
45
|
160
|
60
|
100
|
160
|
87
|
|
| Other Long-Term Assets |
97
|
60
|
157
|
75
|
74
|
8
|
8
|
260
|
|
| Total Assets |
107 390
N/A
|
82 822
-23%
|
84 838
+2%
|
94 051
+11%
|
97 377
+4%
|
98 205
+1%
|
93 774
-5%
|
271 272
+189%
|
|
| Liabilities | |||||||||
| Accounts Payable |
6 915
|
4 782
|
3 959
|
6 822
|
4 080
|
6 549
|
7 726
|
14 156
|
|
| Accrued Liabilities |
134
|
121
|
255
|
326
|
227
|
121
|
45
|
11 309
|
|
| Short-Term Debt |
48 732
|
26 954
|
24 711
|
25 071
|
24 775
|
21 661
|
18 045
|
53 327
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
158
|
555
|
506
|
38 604
|
|
| Other Current Liabilities |
6 966
|
3 447
|
5 030
|
3 062
|
4 891
|
6 180
|
3 467
|
27 327
|
|
| Total Current Liabilities |
62 747
|
35 305
|
33 955
|
35 281
|
34 131
|
35 066
|
29 790
|
144 724
|
|
| Long-Term Debt |
0
|
752
|
0
|
0
|
1 817
|
3 329
|
5 709
|
38 016
|
|
| Deferred Income Tax |
2 274
|
2 258
|
2 145
|
1 944
|
1 974
|
842
|
647
|
46 161
|
|
| Total Liabilities |
65 021
N/A
|
38 314
-41%
|
36 100
-6%
|
37 225
+3%
|
37 922
+2%
|
39 237
+3%
|
36 146
-8%
|
228 900
+533%
|
|
| Equity | |||||||||
| Common Stock |
2 289
|
2 289
|
2 289
|
3 075
|
3 075
|
3 075
|
3 075
|
4 687
|
|
| Retained Earnings |
30 197
|
32 337
|
36 567
|
34 644
|
37 274
|
36 786
|
35 446
|
247 920
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
9 225
|
9 225
|
9 225
|
9 225
|
107 968
|
|
| Unrealized Security Profit/Loss |
9 882
|
9 882
|
9 882
|
9 882
|
9 882
|
9 882
|
9 882
|
9 882
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
167 756
|
|
| Total Equity |
42 368
N/A
|
44 508
+5%
|
48 738
+10%
|
56 826
+17%
|
59 456
+5%
|
58 968
-1%
|
57 628
-2%
|
42 371
-26%
|
|
| Total Liabilities & Equity |
107 390
N/A
|
82 822
-23%
|
84 838
+2%
|
94 051
+11%
|
97 377
+4%
|
98 205
+1%
|
93 774
-5%
|
271 272
+189%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
5
|
5
|
5
|
6
|
6
|
6
|
92
|
47
|
|
Switch to:
Switch to:
See Also
Discover More
